Durmanová V, Mosko T, Sapák M, Kosovský J, Rezuchová I, Buc M, Rajcáni J
Institute of Virology, Slovak Academy of Sciences, 84505 Bratislava, Slovak Republic.
Acta Microbiol Immunol Hung. 2006 Dec;53(4):459-77. doi: 10.1556/AMicr.53.2006.4.4.
To compare the immunogenity of the herpes simplex virus 1 (HSV-1/HHV-1) recombinant glycoprotein D (gD1), as a potential protective vaccine, Balb/c mice were immunized with either gD1/313 (the ectodomain of the gD1 fusion protein consisting of 313 amino acid residues), or the plasmid pcDNA3.1-gD (coding for a full length gD1 protein, FLgD1). A live attenuated HSV-1 (deleted in the gE gene), and a HSV-1 (strain HSZP)-infected cell extract served as positive controls, and three non-structural recombinant HSV-1 fusion proteins (ICP27, UL9/OBP and thymidine kinase--TK) were used as presumed non-protective (negative) controls. Protection tests showed that the LD50 value of the challenging infectious virus increased 90-fold in mice immunized with ICP27, but remained unchanged in other control mice immunized with TK and OBP polypeptides. A significant protection (the LD50 value of challenging virus increased 800-fold) was noted following immunization with gD1/313, while immunization with the gE-del virus and/or the gD1 DNA vaccine resulted in a more than 4,000-fold increase of the challenging virus dose killing 50% of the animals. Using ELISA, elevated antibody titers were detected following immunizations with gD1/313, gE-del virus, and/or HSV-1-infected-cell extract. In addition, all of the three non-structural proteins elicited a good humoral response (with titres ranging from 1:16,000 to 1:128,000). The lowest IgG response (1:8,000) was noted after immunization with the gD1 DNA vaccine. Peripheral blood leukocytes (PBLs) as well as splenocytes from mice immunized with gD1/313, gE-del virus, and gD1-plasmid responded in lymphocyte transformation test (LTT) to the presence of purified gD1/313 antigen. For PBLs, the most significant stimulation of thymidine incorporation was registered at a gD1/313 concentration of 5 microg/100 microl, while the splenocytes from DNA vaccine-immunized mice responded already at a concentration of 1 microg/100 microl.
为比较单纯疱疹病毒1型(HSV-1/HHV-1)重组糖蛋白D(gD1)作为一种潜在保护性疫苗的免疫原性,用gD1/313(由313个氨基酸残基组成的gD1融合蛋白的胞外结构域)或质粒pcDNA3.1-gD(编码全长gD1蛋白,FLgD1)免疫Balb/c小鼠。减毒活HSV-1(gE基因缺失)和HSV-1(HSZP株)感染细胞提取物作为阳性对照,三种非结构重组HSV-1融合蛋白(ICP27、UL9/OBP和胸苷激酶-TK)用作假定的非保护性(阴性)对照。保护试验表明,用ICP27免疫的小鼠中,攻击感染病毒的半数致死剂量(LD50)值增加了90倍,但在用TK和OBP多肽免疫的其他对照小鼠中保持不变。用gD1/313免疫后观察到显著的保护作用(攻击病毒的LD50值增加了800倍),而用gE缺失病毒和/或gD1 DNA疫苗免疫导致杀死50%动物的攻击病毒剂量增加了4000倍以上。使用酶联免疫吸附测定(ELISA),在用gD1/313、gE缺失病毒和/或HSV-1感染细胞提取物免疫后检测到抗体滴度升高。此外,所有三种非结构蛋白均引发了良好的体液反应(滴度范围为1:16,000至1:128,000)。用gD1 DNA疫苗免疫后观察到最低的IgG反应(1:8,000)。用gD1/313、gE缺失病毒和gD1质粒免疫的小鼠的外周血白细胞(PBL)以及脾细胞在淋巴细胞转化试验(LTT)中对纯化的gD1/313抗原的存在有反应。对于PBL,在gD1/313浓度为5μg/100μl时记录到最显著的胸苷掺入刺激,而来自DNA疫苗免疫小鼠的脾细胞在浓度为1μg/100μl时就有反应。